Key Points
- CEO Gayn Erickson sold 40,000 Aehr Test Systems shares for approximately $5.23 million, reducing his direct stake by 20.23% to 157,723 shares.
- AEHR’s stock opened at $123.30, near its 52-week high of $133.35, after receiving a $22 million follow-on AI processor order and reporting record bookings of $60.7 million with a backlog of about $100.6 million.
- Institutional investors own 69.69% of the company, while analysts maintain an overall “Buy” rating with a $136.67 consensus price target; however, elevated valuation and additional insider selling could increase profit-taking risk.
Aehr Test Systems (NASDAQ:AEHR - Get Free Report) Director Laura Oliphant sold 1,717 shares of Aehr Test Systems stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $133.00, for a total value of $228,361.00. Following the sale, the director directly owned 16,100 shares of the company's stock, valued at $2,141,300. This trade represents a 9.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Aehr Test Systems Stock Performance
NASDAQ:AEHR opened at $123.30 on Friday. Aehr Test Systems has a 1 year low of $16.38 and a 1 year high of $133.35. The stock has a market cap of $4.02 billion, a P/E ratio of -513.73 and a beta of 3.10. The stock has a 50-day simple moving average of $92.12 and a 200-day simple moving average of $71.00.
Key Aehr Test Systems News
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat order supports demand for Aehr’s FOX systems and strengthens the company’s position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
- Positive Sentiment: Recent updates highlighted record quarterly bookings of $60.7 million, an approximately $100.6 million backlog and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide stronger revenue visibility and reinforce the growth opportunity from AI-chip testing. Aehr’s AI Order and WLBI Opportunity
- Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu are scheduled to meet investors at the Needham Virtual Semiconductor and SemiCap 1x1 Conference on August 19. The event could offer additional insight into demand, backlog conversion and fiscal 2027 execution, although no new financial information was announced. Aehr to Participate in Needham Conference
- Negative Sentiment: Insiders sold a combined 65,130 shares worth approximately $8.5 million on August 12. The sales included 40,000 shares from the CEO, 15,000 from the COO and additional shares from two directors. While the executives retained sizable positions, the transactions may encourage profit-taking and add selling pressure after the stock’s rapid advance. Aehr CEO Stock Sale Filing
- Negative Sentiment: Analyst commentary warns that AEHR now carries demanding expectations following its major gains. Its elevated valuation and negative earnings multiple leave the stock vulnerable to further declines if AI-related orders slow, backlog conversion disappoints or execution falls short.
Hedge Funds Weigh In On Aehr Test Systems
Hedge funds have recently made changes to their positions in the business. BlackRock Inc. purchased a new stake in Aehr Test Systems during the 2nd quarter worth $255,476,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Aehr Test Systems in the second quarter valued at about $64,433,000. Wellington Management Group LLP lifted its stake in shares of Aehr Test Systems by 129.9% during the fourth quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company's stock worth $16,771,000 after purchasing an additional 469,400 shares in the last quarter. Invesco Ltd. boosted its position in shares of Aehr Test Systems by 1,137.2% in the third quarter. Invesco Ltd. now owns 366,570 shares of the semiconductor company's stock worth $11,037,000 after buying an additional 336,940 shares during the period. Finally, Next Century Growth Investors LLC boosted its position in shares of Aehr Test Systems by 99.9% in the fourth quarter. Next Century Growth Investors LLC now owns 552,506 shares of the semiconductor company's stock worth $11,155,000 after buying an additional 276,160 shares during the period. Hedge funds and other institutional investors own 69.69% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on AEHR. Lake Street Capital reissued a "buy" rating and issued a $110.00 target price on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Craig Hallum reissued a "buy" rating and issued a $125.00 target price on shares of Aehr Test Systems in a report on Wednesday, July 15th. Weiss Ratings cut Aehr Test Systems from a "sell (d)" rating to a "sell (e+)" rating in a research report on Wednesday, July 29th. Zacks Research upgraded shares of Aehr Test Systems from a "hold" rating to a "strong-buy" rating in a research report on Friday, July 17th. Finally, Wall Street Zen upgraded shares of Aehr Test Systems from a "sell" rating to a "hold" rating in a report on Saturday, July 18th. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, Aehr Test Systems presently has a consensus rating of "Buy" and an average target price of $136.67.
Check Out Our Latest Stock Analysis on AEHR
Aehr Test Systems Company Profile
(
Get Free Report)
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
